Global Point Of Care (Poc) Molecular Diagnostics Strategic Business Report 2023: Emphasis On Decentralized Diagnostics Presents Opportunities

PCR-based, one of the segments analyzed in the report, is projected to record a 14.4% CAGR and reach US$5.7 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Genetic Sequencing-Based segment is readjusted to a revised 10.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 16.3% CAGR
The Point of Care (POC) Molecular Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2030 trailing a CAGR of 16.3% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11% and 12.6% respectively over the 2022-2030 period.

Within Europe, Germany is forecast to grow at approximately 12.7% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2030.
Select Competitors (Total 64 Featured) -

• Abbott Laboratories
• Bayer AG
• BioMerieux SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Nova Biomedical
• OraSure Technologies, Inc.
• Qiagen Gmbh
• Sekisui Medical Co., Ltd.
• Zoetis Inc.

Key Attributes:

Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW

• Impact of COVID-19 Pandemic and Looming Global Recession
• 2020 Marked as a Year of Disruption & Transformation
• As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
• World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
• Pandemic Puts Intense Pressure on Healthcare Systems & Products Worldwide
• Molecular Diagnostics Receive Healthy Booster from COVID-19 Tests
• Total Number of COVID-19 Tests Conducted and Tests Per Million Population in Most Impacted Countries: As on September 27, 2021
• Molecular Point-of-Care Tests for COVID-19 Witness Rapid Growth
• Molecular RT-PCR Emerges as the Frontline Technology for Testing COVID-19
• Select Commercial Molecular Tests for COVID-19
• CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19 Diagnostic Market
• COVID-19 Affects Demand for Non- COVID Diagnostics
• Point of Care (POC) Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
• Molecular Diagnostics: Leveraging Molecular Technologies to Monitor Human Diseases
• Types of Molecular Diagnostics Tests
• An Introduction to Point of Care (POC) Molecular Diagnostics
• Molecular Testing Mechanisms
• Molecular Vs Non-Molecular POCT
• Global Market Prospects & Outlook
• PCR Technology Leads the MDx Market
• Infectious Diseases: The Largest Application Market
• Reagents and Kits Dominate the Molecular Diagnostics Market
• Developing Countries Present Strong Growth Prospects
• Competition
• Recent Market Activity

2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS

• Rising Demand for Point of Care Diagnostics Augurs Well for Molecular POC Diagnostics Market
• Emphasis on Decentralized Diagnostics Presents Opportunity for POC Testing
• Faster Screening Necessitates Point-of-care Diagnostics for COVID-19 Pandemic
• Growing Prevalence of Infectious Diseases Spurs Need for POC Molecular Diagnostics
• Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
• Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
• PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
• Rising Prevalence of Respiratory Infections to Drive Need for POC Molecular Diagnostics
• Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
• Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Market Opportunities
• Percentage Share Breakdown of Global Deaths Linked to Air Pollution
• Air Pollution Levels (PM2.5 Concentration (?g/m) for Major Countries Worldwide for 2020
• Rising Cancer Incidence Drives Focus onto POC Molecular Diagnostics
• Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
• Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
• Number of New Cancer Cases and Deaths (in Million) by Region for 2020
• Rising Incidence of Hospital Acquired Infections (HAIs) Propels Demand for POC Molecular Diagnostics
• Sustained Threat of HIV and Sexually Transmitted Diseases Amplify Need for POC Molecular Diagnostics
• Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
• Number of AIDS-Related Deaths (in Thousands) by Region for 2018
• Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
• Home HIV Testing Emerges as a Lucrative Option
• Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
• Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
• Hepatitis B Prevalence Worldwide by Region
• Demand Continues to Surge for CLIA-Waived Molecular POC Tests
• Advancements in POC for Molecular Diagnostics to Drive Market Growth
• Nanotechnology Facilitates Development of for POC Molecular Diagnostics
• Healthcare Needs of the World's Aging Population: Potential Opportunity in Store
• Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
• Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
• Increase in Healthcare Spending in Emerging Markets to Propel Demand for POC Molecular Diagnostics
• World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
• Elderly Healthcare Expenditure as a % of GDP for 1970, 2010 and 2050
• Challenges Facing POC Molecular Diagnostics Market

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS
IV. COMPETITION

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• global market for point of care (poc) molecular diagnostics

MENAFN11072023004107003653ID1106583160